New Warnings for MS Drug Gilenya After FDA Review

Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug?s possible heart risks, according to a company statement.

Source: http://www.webmd.com/multiple-sclerosis/news/20120420/new-warnings-for-ms-drug-gilenya-after-fda-review?src=RSS_PUBLIC

effective weight loss effective weight loss diet jillian michaels